Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) is a publicly traded Healthcare sector company. As of November 12, 2026, TAK trades at $21.45 with a market cap of $66.87B and a P/E ratio of 0.00. TAK moved +2.93% today. Year to date, TAK is +32.92%; over the trailing twelve months it is +48.86%. Its 52-week range spans $12.99 to $21.73. Analyst consensus is buy with an average price target of $42.90. Rallies surfaces TAK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TAK, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $21.45 |
| Market Cap | $66.87B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.31% |
| 52-Week High | $21.73 |
| 52-Week Low | $12.99 |
| Volume | 3.92K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover TAK: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $42.90.